{
    "id": 6522,
    "name": "mixed cell uveal melanoma",
    "source": "DOID",
    "definition": null,
    "currentPreferredTerm": null,
    "lastUpdateDateFromDO": "03/24/2020",
    "altIds": [
        
    ],
    "termId": "DOID:6522",
    "evidence": [
        
    ],
    "clinicalTrials": [
        {
            "nctId": "NCT02223819",
            "title": "Adjuvant Crizotinib in High-Risk Uveal Melanoma Following Definitive Therapy",
            "phase": "Phase II",
            "recruitment": "Active, not recruiting",
            "therapies": [
                {
                    "id": 706,
                    "therapyName": "Crizotinib",
                    "synonyms": null
                }
            ]
        }
    ]
}